Relative efficiency of precision medicine designs for clinical trials with predictive biomarkers-Reference-Cited by-同舟云学术

Relative efficiency of precision medicine designs for clinical trials with predictive biomarkers

Published:2017-12-04 Issue:5 Volume:37 Page:687-709
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Shih Weichung Joe¹²^ORCID,Lin Yong¹²

Affiliation:

1. Department of Biostatistics, School of Public Health; Rutgers, The State University of New Jersey; 683 Hoes Lane West Piscataway NJ 08854 USA

2. Division of Biometrics, Rutgers Cancer Institute of New Jersey; Rutgers, The State University of New Jersey; 195 Little Albany Street New Brunswick NJ 08901 USA

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference21 articles.

1. Issues in clinical trial designs for tumor marker studies;Sargent;Semin Oncol,2002

2. Randomized clinical trials with biomarkers: design issues;Freidlin;J Natl Cancer Inst,2010

3. Hayes DF A bad tumor marker test is as bad a bad drug: the case for more consistent regulation of cancer diagnostics http://connection.asco.org/blogs

4. Evaluating the efficiency of targeted designs for randomized clinical trials;Simon;Clin Cancer Res,2004

5. On the efficiency of targeted clinical trials;Maitournam;Stat Med,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two-stage Adaptive Enrichment Designs with Survival Outcomes and Adjustment for Misclassification in Predictive Biomarkers;Statistics in Biopharmaceutical Research;2024-08-29

2. Confirmatory prediction-driven RCTs in comparative effectiveness settings for cancer treatment;British Journal of Cancer;2023-01-23

3. Assessment of the Clinical Utility of PretreatmentDPYDTesting for Patients Receiving Fluoropyrimidine Chemotherapy;Journal of Clinical Oncology;2022-11-20

4. Defining Clinical Utility of Germline Indicators of Toxicity Risk: A Perspective;Journal of Clinical Oncology;2022-06-01

5. A twelve-gene signature for survival prediction in malignant melanoma patients;Annals of Translational Medicine;2020-03